A mechanistic study on the chemical and enzymatic degradation of PEG-Oligo(ε-caprolactone) micelles

被引:46
作者
Carstens, Myrra G. [1 ,2 ]
van Nostrum, Cornelius F. [1 ]
Verrijk, Ruud [2 ]
De Leede, Leo G. J. [2 ]
Crommelin, Daan J. A. [1 ]
Hennink, Wim E. [1 ]
机构
[1] Univ Utrecht, Fac Pharmaceut Sci, UIPS, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
[2] OctoPlus NV, Leiden, Netherlands
关键词
biodegradable polymers; micelle; stability; polymer biodegradation; polymeric drug carrier; pegylation; enzymes;
D O I
10.1002/jps.21092
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The chemical and enzymatic degradation of monodisperse oligo(epsilon-caprolactone) (OCL) and its amphiphilic block oligomer with methoxy poly(ethylene glycol) (mPEG) were investigated in order to obtain insight into the degradation of mPEG-b-OCL micelles. Hydrolytic degradation was studied as function of pH and dielectric constant of the medium, and enzymatic degradation was investigated at different enzyme and substrate concentrations. The degradation was monitored by HPLC and MS, and the micelle destabilization with DLS. It was found that the hydrolytic degradation followed pseudo first order kinetics, and that the rate depended on the pH and dielectric constant. Degradation essentially occurred via a random scission process, and induced micelle destabilization after approximately 1.5 degradation half-lives. At physiological pH and temperature, OCLs are very stable, reflected by an estimated degradation half-life of mPEG-b-OCL micelles of several years. However, the presence of lipase resulted in an accelerated degradation with half-lives of a few days to hours. The enzymatic degradation of mPEG-b-OCL followed Michaelis-Menten kinetics. The results indicate that mPEG-b-OCL micelles, are very stable in vitro, but their susceptibility to enzymes such as lipase makes these systems suitable for the hydrolysis controlled release of drugs in vivo. (C) 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm. Sci 97:506-518, 2008.
引用
收藏
页码:506 / 518
页数:13
相关论文
共 38 条
[1]   Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution [J].
Aliabadi, HM ;
Brocks, DR ;
Lavasanifar, A .
BIOMATERIALS, 2005, 26 (35) :7251-7259
[2]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[3]  
ATTWOOD D, 1983, SURFACTANT SYSTEMS T, P108
[4]   Small oligomeric micelles based on end group modified mPEG-oligocaprolactone with monodisperse hydrophobic blocks [J].
Carstens, Myrra G. ;
Bevernage, Jan J. L. ;
van Nostrum, Cornelus F. ;
van Steenbergen, Mies J. ;
Flesch, Frits M. ;
Verrijk, Ruud ;
de Leede, Leo G. J. ;
Crommelin, Daan J. A. ;
Hennink, Wim E. .
MACROMOLECULES, 2007, 40 (01) :116-122
[5]   Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybutyrate) and poly(ethylene glycol) as drug carriers [J].
Chen, Cheng ;
Yu, Chung Him ;
Cheng, Yin Chung ;
Yu, Peter H. F. ;
Cheung, Man Ken .
BIOMATERIALS, 2006, 27 (27) :4804-4814
[6]   Polycaprolactone microparticles and their biodegradation [J].
Chen, DR ;
Bei, JZ ;
Wang, SG .
POLYMER DEGRADATION AND STABILITY, 2000, 67 (03) :455-459
[7]   New insights into the hydrolytic degradation of poly(lactic acid): participation of the alcohol terminus [J].
de Jong, SJ ;
Arias, ER ;
Rijkers, DTS ;
van Nostrum, CF ;
Kettenes-van den Bosch, JJ ;
Hennink, WE .
POLYMER, 2001, 42 (07) :2795-2802
[8]   In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(ε-caprolactone) micelles [J].
Forrest, ML ;
Won, CY ;
Malick, AW ;
Kwon, GS .
JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) :370-377
[9]   Enzymatic biodegradation of poly(ethylene oxide-b-ε-caprolactone) diblock copolymer and its potential biomedical applications [J].
Gan, ZH ;
Jim, TF ;
Li, M ;
Yuer, Z ;
Wang, SG ;
Wu, C .
MACROMOLECULES, 1999, 32 (03) :590-594
[10]   Block copolymer micelles: preparation, characterization and application in drug delivery [J].
Gaucher, G ;
Dufresne, MH ;
Sant, VP ;
Kang, N ;
Maysinger, D ;
Leroux, JC .
JOURNAL OF CONTROLLED RELEASE, 2005, 109 (1-3) :169-188